Figure 4

PCA analysis of all patients. (D) DALPMs had better discrimination in terms of patient risk compared with (A) all genes, (B) disulfidptosis genes, and (C) all disulfidptosis lncRNAs.

PCA analysis of all patients. (D) DALPMs had better discrimination in terms of patient risk compared with (A) all genes, (B) disulfidptosis genes, and (C) all disulfidptosis lncRNAs.